RT Book, Section A1 Holm, Tammy M. A1 Parangi, Sareh A2 Morita, Shane Y. A2 Balch, Charles M. A2 Klimberg, V. Suzanne A2 Pawlik, Timothy M. A2 Posner, Mitchell C. A2 Tanabe, Kenneth K. SR Print(0) ID 1145757572 T1 Hürthle Cell Carcinoma T2 Textbook of Complex General Surgical Oncology YR 2018 FD 2018 PB McGraw-Hill Education PP New York, NY SN 9780071793315 LK accesssurgery.mhmedical.com/content.aspx?aid=1145757572 RD 2024/10/10 AB Hürthle cell carcinoma is a rare subtype of well-differentiated thyroid cancer representing 3% to 4% of all thyroid malignancies.1 First described by Max Askanazy in 1898 and then erroneously attributed to Karl Hürthle 30 years later, Hürthle cell carcinoma continues to perplex even experienced endocrine surgeons and surgical oncologists due to the rarity of disease as well as the somewhat variable natural history.